olam food ingredients (ofi) marks dairy milestone adding manufacturing capacity to meet the needs of customers across the Middle East and Africa

Through commissioning a new milk powder dryer and gravity flow production system, ofi remains laser focused on servicing customers across the Middle East and Africa SINGAPORE – EQS Newswire – 16 October 2023 – Expands plant facility & strengthens capabilities of Ingredient Excellence Center in Malaysia; New category labs with state-of-the-art R&D equipment enabling production […]

Read More

Bombardier To Provide Product, Services and Sustainability Updates as part of NBAA-BACE Press Conference in Las Vegas

MONTREAL, Oct. 16, 2023 (GLOBE NEWSWIRE) — As part of NBAA-BACE Media Day, Bombardier leaders, including President and CEO Éric Martel, will outline key in-service milestones on the growing flagship fleet of Global 7500 aircraft, as well as confirm and detail on-track progress for the Global 8000 aircraft’s flight testing. “We are proud to showcase […]

Read More

Bybit Introduces Double-Win, a Revolutionary Trading Tool to Capture Market Movements

DUBAI, UNITED ARAB EMIRATES – Media OutReach – 16 October 2023 – Bybit, the world’s third most visited crypto exchange, is thrilled to announce the launch of Double-Win, an innovative trading tool designed to empower users and maximize profit potential in the dynamic crypto market. Double-Win is a groundbreaking short-term structured product that enables users to react swiftly to […]

Read More

Atos Cloud Computing, the first authorized foreign-funded company to operate data centre and cloud computing services nationwide in China, renews its Value-Added Telecommunication Services licenses

Wuhan, China – October 16, 2023 – Atos has renewed its Value-Added Telecommunication Services licenses (VATS licenses) in China, enabling it to run world class digital services and data centers across the country. Atos Cloud Computing has retained the licenses since 2019, being the first authorized foreign-funded company to operate cloud computing VATS regulated activities […]

Read More

MoonLake Immunotherapeutics announces the full dataset from its 24-week MIRA clinical trial, establishing the Nanobody® sonelokimab as a highly promising and differentiated therapeutic solution for Hidradenitis Suppurativa

MoonLake Immunotherapeutics announces the full dataset from its 24-week MIRA clinical trial, establishing the Nanobody® sonelokimab as a highly promising and differentiated therapeutic solution for Hidradenitis Suppurativa (HS) Maintenance treatment with sonelokimab dosed every 4 weeks (Q4W), demonstrated that 57% of patients achieved HiSCR75 at week 24, increasing the landmark week 12 responses (primary endpoint) […]

Read More